TipRanks
Go Ultimate55% OFF

Koken Ltd. (7963) AI Stock Analysis

Top Page

JP:7963

Koken Ltd.

(TSE/TYO:7963)

Select Model
Rating:62Neutral
Price Target:JPY 1,907.00â–²(10.42% Upside)
Action:reiterated
Date:08/07/26

The score is held back primarily by weak and volatile cash generation in 2025 (negative free cash flow despite profitability). Offsetting this are improving revenue momentum and a stable, de-risking balance sheet, while valuation is attractive (low P/E with a decent dividend). Technicals are mixed, indicating neither strong upside momentum nor significant breakdown.

Positive Factors
Revenue ReaccelerationThe return to stronger top-line growth after a flat 2023 and modest 2024 suggests improving demand and renewed commercial momentum, supporting the company’s ability to expand its operating base over the next several months.
Negative Factors
Negative Free Cash FlowNegative free cash flow despite reported profitability raises concerns about earnings quality and internal funding capacity. If sustained, elevated working-capital needs or capital spending could constrain investment and financial flexibility.

Koken Ltd. (7963) vs. iShares MSCI Japan ETF (EWJ)

-10%-5%0%5%10%15%20%25%JP:7963-5.27%EWJ+15.87%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
JPY 8.36B
Dividend Yield
2.90%
Average Volume (3M)
4,588
Price to Earnings (P/E)
10.1
Beta (1Y)
0.35
Revenue Growth
9.02%
EPS Growth
8.88%
Country
Japan
Employees
312
Sector
General
Sector Strength
55
Industry
Medical - Devices

Koken Ltd. Business Overview & Revenue Model

Company Description

Koken Ltd., along with its subsidiaries, specializes in the production and sale of personal protective equipment for occupational use and products designed to enhance environmental quality throughout Japan. The company organizes its diverse operation...

How the Company Makes Money

null

Koken Ltd. Financial Statement Overview

Summary

Income statement and balance sheet are solid (re-accelerating revenue growth in 2025 and improving leverage), but cash flow is a major weakness: 2025 operating cash flow fell sharply and free cash flow turned negative, raising earnings-quality and near-term flexibility concerns.

Income Statement

72Positive

Balance Sheet

74Positive

Cash Flow

38Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue12.06B11.86B10.76B10.59B10.60B10.20B
Gross Profit5.41B5.38B4.92B4.84B4.99B4.65B
EBITDA1.59B1.70B1.49B1.51B1.80B1.88B
Net Income838.77M885.29M722.06M701.13M833.11M862.37M
Balance Sheet
Total Assets21.38B22.44B20.95B20.87B20.62B19.64B
Cash, Cash Equivalents and Short-Term Investments2.84B2.68B2.53B2.98B2.39B2.19B
Total Debt5.47B5.79B5.18B6.05B6.13B6.13B
Total Liabilities7.62B8.65B7.91B8.52B8.80B8.52B
Stockholders Equity13.77B13.80B13.04B12.35B11.82B11.11B
Cash Flow
Free Cash Flow0-232.16M445.38M886.94M451.74M417.31M
Operating Cash Flow0136.14M666.37M1.08B618.95M655.48M
Investing Cash Flow0-379.51M-98.81M-206.25M-184.20M147.58M
Financing Cash Flow0370.84M-1.05B-307.82M-291.98M-176.25M

Koken Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price1727.00

Price Trends

50DMA1792.40Negative
100DMA1780.93Negative
200DMA1853.61Negative

Market Momentum

MACD-23.52Positive
RSI38.52Neutral
STOCH26.96Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7963, the sentiment is Negative. The current price of 1727.00 is below the 20-day moving average (MA) of 1766.20, below the 50-day MA of 1792.40, and below the 200-day MA of 1853.61, indicating a bearish trend. The MACD of -23.52 indicates Positive momentum. The RSI at 38.52 is Neutral, neither overbought nor oversold. The STOCH value of 26.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7963.

Koken Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7963 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6678JP:667882OutperformJPY 18.42B12.22―5.97%20.88%44.61%
JP:6823JP:682378OutperformJPY 37.69B10.85―3.11%2.48%11.43%
JP:5187JP:518770OutperformJPY 10.13B16.49―4.31%5.20%-17.92%
JP:7963JP:796362NeutralJPY 8.49B10.10―2.90%9.02%8.88%
JP:6523JP:652358NeutralJPY 180.17B19.535.76%2.97%3.04%-19.26%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:7600JP:760047NeutralJPY 15.22B-69.06―2.94%-6.64%67.08%

* General Sector Average

Performance Comparison

0%25%50%75%100%JP:7963JP:6523JP:5187JP:6678JP:6823JP:7600Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
JP:7963 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7963Koken Ltd.1727.00-96.08-5.27%
JP:6523PHC Holdings Corp.1415.00438.8844.96%
JP:5187Create Medic Co., Ltd.1114.00129.5713.16%
JP:6678Techno Medica Co., Ltd.2161.00335.3418.37%
JP:6823Rion Co., Ltd.3055.00629.4925.95%
JP:7600Japan Medical Dynamic Marketing, Inc.578.00115.0124.84%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 06, 2026